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Abstract
Background: Bipolar disorder (BD) is commonly associated with cognitive and functional impairments even during
remission periods, and although a growing number of studies have demonstrated the benefits of psychotherapy as
an add-on to pharmacological treatment, its effectiveness appears to be less compelling in severe presentations of
the disorder. New interventions have attempted to improve cognitive functioning in BD patients, but results have
been mixed.
Methods: The study consists of a clinical trial comparing a new structured group intervention, called “Cognitive-
Behavioral Rehabilitation,” with treatment as usual (TAU) for bipolar patients. The new approach is a combination
of cognitive behavioral strategies and cognitive remediation exercises, consisting of 12 weekly group sessions of
90 min each. To be included in the study, patients must be diagnosed with BD type I or II, aged 18–55 years, in full
or partial remission, and have an IQ of at least 80. A comprehensive neuropsychological battery, followed by mood,
social functioning, and quality of life assessments will occur in three moments: pre and post intervention and
12 months later. The primary outcome of the study is to compare the time, in weeks, that the first full mood
episode appears in patients who participated in either group of the study. Secondary outcome will include
improvement in cognitive functions.
Discussion: This is the first controlled trial assessing the validity and effectiveness of the new “Cognitive-Behavioral
Rehabilitation” intervention in preventing new mood episodes and improving cognitive and functional impairments.
Trial registration: Clinicaltrial.gov, NCT02766361. Registered on 2 May 2016.
Keywords: Bipolar disorder, Psychotherapy, Treatment as usual, TAU, Cognitive rehabilitation, Functional impairment,
Cognitive functioning, Cognitive-Behavioral Rehabilitation
Background
Bipolar disorder (BD) is a severe medical condition often
associated with functional impairments even when
affected individuals are euthymic [1]. Many studies re-
port cognitive deficits in this population, most often in
executive functions [2], attention [3], and verbal memory
[4], which is coherent with recent meta-analyses on this
topic [5, 6]. Recent studies have also established an asso-
ciation between cognitive deficits and functional impair-
ments [7]. This evidence leads some authors to suggest
that bipolar patients should benefit from cognitive
rehabilitation strategies similar to those conducted in
patients with schizophrenia [8].
Structured psychotherapies for BD associated with
standard pharmacotherapy are associated with longer
periods of remission, reduction in manic and depressive
symptomatology, and faster recovery from episodes
when compared to pharmacological treatment alone [9].
The majority of current studies suggest psychotherapy
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as an add-on to pharmacological treatment, even during
euthymic periods [10].
Some studies have reported negative results regarding
the effects of psychotherapies in preventing new mood
episodes in BD [11]. A multicenter study including 253
patients with BD, in a heterogeneous sample with pa-
tients in diverse mood states, identified that Cognitive
Behavior Therapy (CBT) prevented new mood episodes
only in patients with less than 12 previous episodes [12].
Similar negative results in recovering and preventing
mood episodes were found in group psychotherapy set-
tings [13, 14]. The effectiveness of structured approaches
most likely depends on the number of previous mood
episodes [15]. Most negative studies included more se-
vere presentations of BD, often including patients with
more than two co-morbidities or many previous mood
episodes; these observations have guided some re-
searchers to delineate the importance of a staging model
in BD [16].
Due to the disabling cognitive impairments in BD,
new interventions were developed, namely cognitive re-
habilitation and functional remediation. The first term
describes a cognitive-oriented approach, developed to
enhance specific cognitive domains such as attention
and executive functioning [17]. The second one claims
to enhance these same domains using an ecologic
method in day-by-day tasks [18]. Despite such differ-
ences, we have chosen to use the term “cognitive
remediation” to describe both approaches after consider-
ing the lack of evidence in this field. Deckersbach et al.
[17] ran an open trial with 18 bipolar patients presenting
depressive symptoms. After 14 individual sessions of
cognitive remediation, patients demonstrated lower re-
sidual depressive symptoms and increased occupational
and psychosocial functioning; the results persisted after
three months. Another trial, conducted by Torrent et al.
[19], evaluated cognitive remediation, delivering 21
weekly sessions in a group format. It consisted of three
arms: (1) functional remediation; (2) psychoeducation;
and (3) standard pharmacological treatment (TAU). The
study included 239 euthymic, type I and type II bipolar
patients, employing the Functioning Assessment Short
Test (FAST) as the main outcome. Results suggest that
psychoeducation and group cognitive remediation were
better than TAU in improving functioning. Theory of
mind [20] guided a new intervention designed to im-
prove social cognition in BD [21]. The study included 37
patients randomly assigned to 18 group sessions of
Social Cognition and Interaction Training (SCIT) or
TAU alone. The SCIT group revealed an improvement
in emotional perception and a decrease in depressive
symptomatology. Lastly, Demant et al. [22] developed a
12-week group intervention of cognitive remediation.
Their first trial included 46 BD patients, partially or fully
remitted, randomly assigned to either cognitive remedi-
ation or standard treatment. The 26-week follow-up re-
vealed no statistical differences in executive function,
verbal memory, sustained attention, and psychosocial
behavior, despite participants in the cognitive remedi-
ation group reporting a significant improvement in ver-
bal fluency and quality of life [23].
These innovative trials encouraged the emerging field
of cognitive remediation in BD. Cognitive remediation
seems to be a feasible and partially efficacious method
for treating residual depressive symptoms and improving
functional recovery. Paradoxically, it is unclear whether
such interventions are capable of promoting cognitive
recovery in BD patients, the core reason for its creation.
Traditionally, cognitive remediation methodologies
employ task-focused approaches. However, when testing
its efficacy, restrictive settings are often utilized [24],
which brings criticism for creating low ecological validity
(i.e. the individual shows improvement in a specific task,
but does not transfer it into their daily lives); conse-
quently, new approaches are being proposed rather fo-
cusing on daily tasks [18].
Current psychological interventions for BD focus on
the reduction of mood symptomatology and preven-
tion of new bipolar episodes [25] and although these
interventions may secondarily improve cognitive im-
pairments, new psychological approaches enabling BD
patients to deal with future episodes and addressing
cognitive deficits are desirable.
This study aims to evaluate the effectiveness of a new
intervention that combines cognitive rehabilitation and
CBT strategies. Cognitive Behavioral Rehabilitation (CBR)
was designed in an attempt to create a new intervention
that could not only prevent new mood episodes (main
outcome) but also improve memory, attention, executive
functioning (secondary outcomes), and enhance quality of
life (tertiary outcome).
Hypotheses
The study hypothesizes that CBR, compared with TAU,
will:
(1) Expand the period of time until the first new
episode—our primary outcome measure;
(2) Improve attention, mental flexibility, working
memory, and emotional recognition—
our secondary outcome.
In an exploratory analysis, we will also assess whether
CBR:
(1) Enhances functional, social skills, and quality of life
scores;
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(2) Increases sleep quality and knowledge about the
disorder; and
(3) Reduces impulsivity.
Methods/Design
The study compares CBR with TAU, the latter being
the commonly offered pharmacological treatment to bi-
polar patients. The psychological intervention will con-
sist of 12 weekly group sessions, lasting 90 min each,
and including eight to ten individuals. Participants will
be randomly assigned to one of the two arms and
followed for 12 months thereafter (Fig. 1). During the
entire study, all patients will be medicated accordingly
to their clinical needs and all changes in medication
will be recorded, following the Necessary Clinical Ad-
justment (NCA) instrument. The NCA records medica-
tion adjustments implemented to reduce symptoms,
improve response and functioning, or handle unbear-
able side effects [26].
Participants
In order to be included, patients must be aged 18–55
years, literate, present an IQ score higher than 80, have
been diagnosed with bipolar I or II based on Structured
Interview for DMS IV (SCID) [27], and be in full or par-
tial remission according to the DSM IV [28]. Exclusion
criteria are: presence of substance or alcohol abuse in
the last six months; current suicide risk; organic mental
disorders; or scores higher than 12 in the Montgomery-
Åsberg Depression Rating Scale (MADRS) or the Young
Mania Rating Scale (YMRS) at the beginning of the
intervention [28].
Recruiting will take place at an outpatient service pro-
vided by the Bipolar Disorder Research Program (PRO-
MAN) at the University of São Paulo Medical School,
Brazil. Patients will receive invitations individually and
sign an informed consent. This research was approved
by an internal ethical committee and registered in Clini-
calTrials.gov: NCT02766361.
Procedure and outcomes
Once included, patients will complete the Portuguese
versions of the following self-report questionnaires:
 Abbreviated instrument of quality of life
(WHOQOL-bref ) [29]: evaluating quality of life
scored in four domains: physical, psychological
social, and environmental
Fig. 1 Schedule of enrolment, interventions, and assessments of study
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 Barratt Impulsiveness Scale 11 (BIS 11) [30]:
assessing the personality/behavioral construct
of impulsiveness. It includes 30 items describing
common impulsive or non-impulsive behaviors
and preferences
 Social Skills Inventory (IHS) [31]: self-report
instrument assessing social skills. It consists of 38
items, each describing a situation of interpersonal
relationship and a demand for ability to react to
that situation
 Biological Rhythms Interview of Assessment in
Neuropsychiatry (BRIAN) [32]: consisting of 21
items divided into five main areas related to
circadian rhythm disturbances in psychiatric
patients, including sleep, activities, social rhythms,
eating patterns, and predominant rhythm
 Functioning Assessment Short Test (FAST) [33]:
a 24-item interview assessing functional impairments
in BD, and including autonomy, occupational
functioning, cognitive, financial issues, interpersonal
relationships, and leisure time
 Knowledge about Affective Disorders Interview
(KADI): brief questionnaire evaluating the patient’s
knowledge about prognostic, medication, etiology,
symptoms, and diagnosis of BD [34]
A brief neuropsychological battery will be conducted,
which includes two subtests of matrix reasoning and
vocabulary from the Wechsler Abbreviated Scale of
Intelligence (WASI) [35] and following subtests from the
Cambridge Neuropsychological Test Automated Battery
(CANTAB): Motor Screening Task (MOT); Rapid Visual
Information Processing (RVP); Reaction Time (RTI);
Spatial Span (SSP); Spatial Working Memory (SWM);
One Touch Stockings of Cambridge (OTS); Pattern Rec-
ognition Memory (PRM); Delayed Matching to Sample
(DMS); Attention Switching Task (AST); and Emotion
Recognition Task (ERT).
Participants will also complete the initial assessment
and mood module of the Structured Clinical Interview
for DSM-IV (SCID-IV) [36] at week 12 after inclusion
into the study and 12 months thereafter.
Interventions
Treatment as usual (TAU)
The control group from this study will receive standard
outpatient treatment offered in our clinic, which involves
psychopharmacological mood stabilization and regular
contacts with mental health nurses. The type and dosage
of pharmacological treatment will follow the physician
decision, respecting individual demands. All pharmaco-
logical treatment will be monitored and recorded in ac-
cordance to the Litmus study [26].
Cognitive Behavioral Rehabilitation (CBR)
We developed a 12-session intervention combining pre-
vious experience in cognitive behavior therapy for bipo-
lar patients [14] with several elements of cognitive
remediation. The first step was to identify behaviors that
have an important role in patients’ autonomy, followed
by determining which cognitive domains are involved.
The core objective was to promote the generalization of
the learnt behaviors in the daily routine. Described
below is the arrangement of each session, divided into
three major modules.
The first module comprises four sessions attempting
to improve attention and memory, considering the ne-
cessity to retain the information discussed throughout
the sessions. There are two target behaviors involved:
adherence to pharmacological treatment and mood
monitoring. The cognitive remediation exercises seek to
enhance verbal and visual memories, while secondarily
enhancing attention with the paper material included in
the manual. In the first session, group members and psy-
chotherapists introduce themselves, followed by a dis-
cussion regarding the manual, individual’s expectations,
and the importance of attendance. The second session
explores the concept of attention and its importance as
a door to further cognitive functions; the group also
learns exercises aimed at training attention and memory.
The third session focuses on medication adherence and
its relation to attention. The core of the third session is
the organization of the patient’s environment, which is
frequently chaotic; a discussion about cues is encouraged
at the end of the session. The fourth session starts by
introducing mood graphics to patients and the import-
ance of the early identifying of mood episodes. At the
end of the first module, patients are encouraged to cook
as a method of reinforcing what they have learned while
enhancing their autonomy.
The second module targets social cognition and com-
munication. The fifth session familiarizes the patients
with the concept of automatic thoughts [37] and a guide
to identify its presence. Cognitive distortions are dis-
cussed along with examples provided by the participants’
own experiences. The sixth session begins returning to
the initial theme by habituating patients to the auto-
matic thought record [38]; patients are stimulated to re-
structure their own thoughts during experiences
identified in previous sessions. Mental flexibility and em-
pathy are introduced and discussed. The seventh session
acquaints patients with assertive communication and
emotion recognition by teaching role-playing exercises
and the importance of positive assertiveness. The eighth
session follows the same agenda as the seventh.
The last module of CBR aims at problem-solving strat-
egies and relapse prevention. The ninth session begins
with the identification of personal problems, mainly by
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distinguishing it from preoccupations; the topic is im-
portant because patients often incorporate their prob-
lems to expectations and desires, generating an urge to
abandon them. The session ends by emphasizing the im-
portance of mental flexibility in generating as many re-
sponses as possible to each identified problem. In the
tenth session, patients learn solving-problem techniques
in a systematic setting. The 11th session is devoted to
reviewing information and clarifying possible doubts
from the patients; patients are also encouraged to debate
the importance of regular routines and regular sleep,
which can be adjusted using sleep hygiene techniques. A
progressive muscle relaxation ends the session. Finally,
the last session’s target is to avoid future mood relapses,
by returning to the personal goals defined in the first
session and prompting patients to develop a prevention
plan. The acronym H.U.M.O.R. resumes the core points
of the post-intervention maintenance program: (1)
Habituate to a regular routine; (2) Use what you have
learnt; (3) Monitor your mood; (4) Observe arising prob-
lems and deal effectively with it; and (5) Respond to
automatic thoughts. All patients in the CBR group will
also receive TAU.
Statistical analysis
Sample size
The sample size calculation was based on the proportion
of patients that remain episode-free after 12 months fol-
lowing a group intervention. Previous studies utilizing
TAU exhibited a decrease of bipolar relapses in 30% of
patients after a one-year follow-up [39]. The present
study anticipates a 55% success rate in prevention of
mood relapses, during the same period, in patients
assigned to the CBR. Thus, considering an 80% power to
obtain a 5% significance, an estimated sample of 28 indi-
viduals per group, 56 in total, should be sufficient to
achieve significant results. A previous study conducted
by the same research team [14] measured a drop-out
rate of 10% in a one-year follow-up. For this latter rea-
son, the study will consist of 60 participants.
Baseline and follow-up data
In order to measure the effectiveness of the intervention,
the study will employ the following statistical tests: (1)
Chi-squared and Mann–Whitney to test homogeneity
between the groups at the beginning of the interven-
tions; (2) Student’s t-test or Mann–Whitney to investi-
gate the effects of such interventions, pre and post
treatment, depending on the distribution of the data; (3)
an analysis of variance, with and without adjustment for
mood symptoms scores, IQ and BD duration, for com-
parison between groups; and (4) the Kaplan–Meyer
survival method with log rank test for statistical analysis,
to investigate the survival data between groups, which
measures in weeks, the time to the first episode as an
event. To be considered as an intervention completer,
patients assigned to CBR should attend at least eight
sessions (66.7%). Intent to treat analyses will be con-
ducted in order to include all available data and missing
data will be handled accordingly to the SPIRIT checklist
recommendations (Additional file 1).
Discussion
The trial compares a new psychological intervention, de-
veloped to treat cognitive dysfunction in BD patients,
with TAU, in an attempt to investigate its effects in cog-
nitive functioning and its ability to prevent new mood
episodes. The objective of this study is to understand the
connection between these outcomes and the successful
prophylactic treatment of BD. Previous studies with
more complex presentations of BD failed to prevent fur-
ther episodes [13] or to improve cognitive functioning in
BD patients [23]. Our hypothesis is that the combination
of cognitive behavior therapy and cognitive rehabilitation
should provide relevant and lasting improvements, and
consequently allow for a better generalization of the im-
provements to daily routines.
Limitations
In comparison with previous studies [19], the current
study utilizes a shorter intervention, which may be insuf-
ficient to effectively deal with many aspects of the dis-
order. Further experiments, using a larger samples and
multicenter settings are necessary if this new interven-
tion proves to be beneficial in our original single site
proof-of-concept study.
Perspectives
We hope that this trial will contribute to a better under-
standing of the clinical responses for the two different
treatment approaches being used in this study; the re-
sults may have important clinical implications in the
management of BD patients. Previous negative findings
may be due to an absence of cognitive rehabilitation
strategies in traditional protocols, a limitation we try to
overcome in this study by focusing in daily activities,
and expecting these behaviors to be more easily trans-
lated into clinical improvements and extended periods
of remission.
Trial status
The study is underway and currently includes 40 pa-
tients, of which 29 have completed the initial evaluations
and 11 are currently in the follow-up period following
participation in either CBR meetings or TAU.
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Additional file
Additional file 1: We have included a copy of the SPIRIT checklist.
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